Core Viewpoint - Aokai Co., Ltd. provides pharmaceutical-grade polyethylene glycol (PEG) raw materials and excipients to hundreds of formulation companies in China, primarily used in various drug forms such as injections, oral, and rectal preparations [2] Group 1: Company Overview - Aokai's PEG products are mainly utilized by pharmaceutical companies focusing on cardiovascular, viral cold, and constipation treatments [2] - The company adheres to information disclosure regulations and will provide updates on business and technological advancements through official announcements [2] Group 2: Intellectual Property and Client Structure - Information regarding the patent status of pharmaceutical-grade PEG is publicly available on platforms like the National Intellectual Property Administration [2] - Due to commercial confidentiality, Aokai is unable to disclose detailed information about its client structure to protect the interests of the company and its partners [2]